This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $684,675
Determining the safety and efficacy of microRNA-181a-5p blocker as a potential therapy for the treatment of osteoarthritis
CIHR · 2025 · Principal investigator
- $474,299
Advancing Osteochondral Allograft Transplantation in Canada: A Novel Storage Medium for Extended Tissue Preservation
CIHR · 2024 · Co-investigator
- $1,143,675
Stem cell extracellular vesicles as a regenerative therapy for hypoplastic lungs: Translational studies in lamb fetuses with congenital diaphragmatic hernia.
CIHR · 2024 · Co-investigator
Determining the safety and efficacy of microRNA-181a-5p blocker as a potential therapy for the treatment of osteoarthritis
Principal investigators: Kapoor, Mohit; Koch, Thomas G; Koenig, Judith; Rampersaud, Y. Raja
Keywords: Antisense Oligonucleotide; Cartilage Degeneration; Disease Attenuation; Efficacy; Equine Models; Fetlock Joint; Micro-Rna; Osteoarthritis; Safety; Synovitis
Advancing Osteochondral Allograft Transplantation in Canada: A Novel Storage Medium for Extended Tissue Preservation
Principal investigators: Changoor, Adele; Grynpas, Marc D
Keywords: Cartilage Extracellular Matrix; Chondrocyte Viability; Doxycycline; Focal Cartilage Lesion; Focal Osteochondral Lesion; Hyaluronic Acid; Osteochondral Allograft Transplantation; Storage Media
Stem cell extracellular vesicles as a regenerative therapy for hypoplastic lungs: Translational studies in lamb fetuses with congenital diaphragmatic hernia.
Principal investigators: Zani, Augusto
Keywords: Congenital Diaphragmatic Hernia; Exosomes; Extracellular Vesicles; Fetal Medicine; Fetal Therapy; Lung Development; Pulmonary Hypertension; Pulmonary Hypoplasia; Regenerative Medicine; Stem Cells
An intervertebral disc replacement: a regenerative medicine approach
Principal investigators: Kandel, Rita A
Keywords: Bone Substitute; Crispr/Cas9; Intervertebral Disc; Perfusion Bioreactor; Scaffolds; Tissue Engineering
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.